US$ 21.23
glp-1 and seizures Neuroprotective effects of glucagon-like peptide-1 (GLP-1) analogues in epilepsy associated comorbidities Glucagon-like peptide-1 medicines in neurological
Description
Cardiovascular risk factors without established disease

[DOI] [PMC free article] [PubMed] [Google Scholar] 14.Khan M.M., Khan Z.A., Khan M.A

AbbVie Bayer AG Teva Pharmaceutical Industries Ltd
People starting semaglutide are often managing multiple health conditions
